Korea To Bolster Fast-Track System With Speedier Approvals In Mind
This article was originally published in The Pink Sheet Daily
Executive Summary
With a broad ambition to improve the global competitiveness of its biopharma industry, South Korea is steadily unveiling supportive regulatory measures.